Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy
Crossref DOI link: https://doi.org/10.1038/s41598-021-86014-7
Published Online: 2021-03-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matsumoto, Hidetaka
Hoshino, Junki
Mukai, Ryo
Nakamura, Kosuke
Akiyama, Hideo
Text and Data Mining valid from 2021-03-24
Version of Record valid from 2021-03-24
Article History
Received: 12 February 2021
Accepted: 9 March 2021
First Online: 24 March 2021
Competing interests
: The authors declare no competing interests.